Zicom Group is a technology, engineering, and manufacturing company founded in 1978 that is currently listed on the ASX. It has over 700 employees across locations in Singapore, Australia, Indonesia, Thailand, China, and the US. The company operates across three key clusters: precision engineering & technologies, construction equipment, and marine, oil & gas. Within these clusters, it focuses on automation engineering, contract manufacturing, and product design & development. It also has a medical technology commercialization group called Zicom MedTacc that helps accelerate medical device and life sciences startups.

1. Zicom Group
Technology, Engineering,
Manufacturing

2. Corporate Structure
Zicom Group
(Listed on ASX)
Precision Engineering &
Technologies Cluster
Zicom MedTacc
(Investments & Commercialization)
Iptec
(Technology Development)
Sysmac
(Manufacturing)
Construction
Equipment Cluster
Marine, Oil &
Gas Cluster
Key Information
• Founded in 1978. Currently listed on ASX.
• Employees > 700. Employee ownership in Zicom > 55%
• Direct presence in Singapore (HQ), Australia, Indonesia, Thailand, China, USA
• Business awards: Enterprise 50, Singapore 1000, Ernst & Young Entrepreneur 2008
1. Zicom Pte Ltd
2. Zicom Equipment
1. Foundation Associates
2. FA Geotech
3. Cesco Australia
4. Cesco Equipment
5. Hangzhou Cesco
6. Zicom Cesco Engineering
7. Zicom Thai Hydraulics
1. Zicom MedTacc
2. Iptec
3. Sys-Mac
4. MTA-Sysmac
5. PT Sysmac
6. Biobot Surgical
7. Curiox Biosystems
8. Orion Systems
9. Histoindex
Group Companies by Cluster

3. Our Key Clusters
Principal Products
• Anchor handling towing systems,
Mooring systems, Pipe laying systems.
• Natural gas processing plants,
regulating and metering skids.
• Average value of projects range from
US$1m to US$30m
Customers
• Ministry of Transport, China
• Petroblanga, ONGC, Chevron
Principal Products
• Mobile mixers: used for
transportation and mixing of concrete
carrying loads of 2m3 to 9m3
• Customized mixers: tanning of
leather, mixing of explosives.
• Foundation equipment: piling and
strengthening foundation of buildings
and infrastructures (onshore and
offshore)
Customers
• Readymix companies such as
Hanson, Boral
• Civil construction contractors
• Oil majors such as Haliburton
Principal Activities - Automation Engineering, Contract Product
Manufacturing, Design & Development
Life Sciences & MedTechConsumer Electronics & Semi-Con
Construction Equipment Marine, Oil & Gas Precision Technology & Engineering

4. Brief Overview of Zicom MedTacc Group
Vision
To be a leading Asian Medtech Commercialization Group
• $30M accelerator fund with co-investor SPRING (statutory board under Ministry of Trade and Industry)
• Accelerator Group has more than 30 experienced professionals and subject matter experts.
• Provide a holistic commercialization platform for medical technologies. Key expertise include:
• IP Translation
• Regulatory Affairs and Quality Assurance
• Commercial and Clinical Partnerships
• Marketing and Sales Creation

5. Senior Leadership
Mr. Sim Giok Lak,
Executive Chairman,
Zicom Group
• Founder & Chairman, Zicom
• Director of SPRING
• Member, Biomed Panel, ETPL
• Member, SAB, DxD Hub
• Member, SNEC Incubation Board
• E&Y Entrepreneur 2008 (Industrial)
Engineering & Manufacturing
Mr Sim Kok Yew,
CEO, Sys-Mac
• CEO, Sys-Mac
Group
• Executive Director,
Zicom Group
• Director of Biobot,
Curiox
Mr Gary Lee
CEO, IPTEC
• Previously held
management
positions in
Jabil,
Flextronics,
Sakura Tech, &
Allied
Technologies
Investments & Commercialization
Mr Sim Kok Hwee,
CEO
• Executive Director,
Zicom Group
• Member, Evaluation
Panel, DxD Hub
Mr Peter Cheng
CTO
• Previously held R&D
mgmt positions in Hyflux,
Vestas, Philips
• Member, TECS Panel,
SPRING
Dr Lim Chee Tiong
VP, Commercial
• Previously Asst
Director of MTO,
SingHealth
• R&D Engineer with
J&J
Ms Liew Lai Chee
VP, RA &QA
• More than 20 years
experience in regulatory and
QA
• Previously held management
positions with GE Healthcare
& Covidien
Dr Emril Ali
VP, ANZ
• Previously Senior
Manager, ETPL,
A*Star
• R&D Engineer, IBN,
A*Star
Ms Jenny Lim
CFO
• Group Financial
Controller Zicom Group
• Previously Senior
Manager with EY Audit
Assurance and Taxation

6. Our Clinical Advisers
A/Professor Choolani leads the High-Risk pregnancy Unit of
Maternal-Fetal Medicine Division at the National University
Hospital (NUH), where he and his team were instrumental in
the development of the breakthrough FlashFISH™ technology.
FlashFISH™ is a rapid diagnostic test performed during
amniocentesis that can detect Down syndrome in unborn
babies within three hours.
He is the principle founder of INEX and non-executive director
of the company, and is one of the key drivers in the successful
development of INEX from a small biotech start-up to a leading
women’s health diagnostic company.
A/Professor Choolani received the Benjamin Henry Sheares’
Memorial Lecture Award in 2010 for his outstanding work in
Obstetrics and Gynaecology. He has also been awarded the
National Medical Research Council (NMRC) Clinician Scientist
award for his outstanding contribution to research.
He has published over 100 articles and abstracts in notable
journals and currently chairs the National University of
Singapore’s Leadership in Academic Medicine Clinician
Scientist Unit and the National Healthcare Group’s Clinician
Leadership Research programme
“We Engineer & Manufacture”
Dr Bhuwnesh Agrawal is an industry veteran with a career
in academic and corporate positions spanning over 35
years. He is currently Vice President, Asia Pac and Africa
of Eppendorf AG.
Dr Agrawal spent 15 years at the Free University of Berlin
in research, teaching and patient management at the start
of his career. Subsequently, he worked in the
pharmaceuticals and diagnostics divisions of Boehringer
Mannheim/Roche in a variety of roles from clinical
research, strategy and business development, to
marketing and sales, for more than 20 years.
He has also held various local, regional, global and
corporate responsibilities in Germany, Switzerland and
India, from where he headed the South Asia business for
Roche Diagnostics from 2007-2012 before joining Vela
Diagnostics.
Dr Agrawal is a medical doctor by training with
specializations in Internal Medicine, Clinical
Pharmacology, and Pharmacology and Toxicology from
Germany. He also received his MBA from the Open
University, UK and his PhD from the Free University of
Berlin.
Dr Henry Ho is a Senior Consultant with the department of
urology in Singapore General Hospital. He is also the
Director of the MedTech Office of SingHealth, responsible
for developing innovative medtech solutions within the
SingHealth Group.
He is one of the 3 pioneering urologists involved in the
development of Biobot’s robotic prostate intervention device
that is a first in the world that puts Singapore in the world
map of Urology.
His main research interest is medical engineering. His other
research interests are medical imaging, ablative energy
technology and non-invasive bladder evaluation.
After completing his undergraduate medical degree in
National University of Singapore, he underwent surgical
training to be a general surgeon and sub specialized to an
urologist. Henry completed a clinical Fellowship in robotic
uro-oncology with Prof G Bartsch, Innsbruck, Austria,
followed by Fellowship in Endourology and laser
prostatectomy with Prof A Gross, Hamburg Germany.
Henry's specialty interests lies in minimally-invasive
urological surgery, benign prostate enlargement and uro-
oncology
Assoc. Prof.
Henry Ho
Senior Consultant
Urologist, SGH
Director of MTO,
SingHealth
Assoc. Prof.
Mahesh Choolani
Senior Consultant
ObGyn, NUH
Director of Research
ObGyn, NUH
Dr. Bhuwnesh Agrawal
VP, Asia Pac & Africa
Eppendorf AG

7. Marketing to Early Adopters
• Engagement with early adopters
• Identify appropriate market access consultants &
distributors
Hands On Mentorship
• Singapore based Silver Mentors possessing strategic, industrial, & commercialization experiences
• Focused on grooming startup C-level executives
Network
• Key stakeholder in Singapore’s BioMed ecosystem
• Portfolio companies revenue generating, contributing to
growing market access network
Infrastructure – Commercialization
Mr. GL Sim
• Founder & Chairman, Zicom
• Director of SPRING
• Member, Biomed Panel,
ETPL
• Member, SAB, DxD Hub
• Member, SNEC Incubation
Board
• E&Y Entrepreneur 2008
(Industrial)
Mr. Jim Finley
• Angel investor
• Retired as EVP of
Rolls Royce,
Energy Division
Mr. CL Yap
• Angel investor
• Formerly held
management positions
in ETPL, Becton
Dickinson, ST
Engineering
Mr. R Govindan
• Founder & Chairman,
Mercatus Capital
• Serial entrepreneur &
investor
• Former President of
Fisher Scientific, APAC
Mr KW Ong
• Founder & Director,
Mercatus Capital
• Serial entrepreneur
& investor
• Former CEO of CH
Offshore

8. Our BioMed Portfolio
Minimally invasive robotic platform for targeted prostate biopsy
- MRI-Targeted Biopsy enabled
- FDA, CE, TGA, HSA approved.
- More than 800 patients
- ISO 13485
- Centers of Excellence in Germany, New York, Australia, UK
- Developing treatment applications
Bioinstrumentation for drug discovery
- Validated by top 10 global pharma companies
- Tech leader for suspension cells & luminex based assays
- San Francisco subsidiary
3-D, quantitative, laser-based imaging for tissue diagnostic
- CE approved. FDA, CFDA in process.
- ISO 13485
- Hangzhou subsidiary
- > 3,000 patients tissue samples analyzed for liver diseases
- Tissue Imaging Service Centers in USA, China, Singapore
Biobot Surgical
Background IP:
SGH, NTU
Curiox Biosystems
Background IP: A*Star
Histoindex
Background IP: A*Star
“We Engineer & Manufacture”

9. Our BioMed Portfolio
Prenatal & Women’s Health Diagnostics
- ISO 13485
- Joint lab BGI to offer non-invasive prenatal testing
- Ovacis intra-operative diagnostic kit used to determine
malignancy of ovarian cancer. Results in < 5mins
Medical Imaging Management
- Software solution to transmit and manage image files in
DICOM format for radiology, pathology, & ophthalmology
- Software integration partner for Topcon Japan.
- Developing national screening platform for retinopathy for
SNEC, Singhealth & NHG. Contract awarded by MOHH.
Inex
Background IPs: NUS
Pellucid
“We Engineer & Manufacture”

10. Thank You